On April 29, 2015, DiagnoCure Inc. announced that Yves Fradet, Louise Proulx, Andrew Sheldon, Jacques Simoneau, and Vincent R. Zurawski, were re-elected by shareholders at the 2013 annual and special meeting of shareholders held on April 29, 2015. In addition, the Company stated that shareholders approved and ratified the new by-laws of the Company - including the advanced notice by-law, and approved all unallocated options under Company's stock option plan.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 43 | |
+48.04% | 58.06B | |
-6.07% | 40.53B | |
+37.74% | 38.99B | |
+12.97% | 26.7B | |
-12.01% | 26.56B | |
-21.70% | 18.98B | |
+0.83% | 12.17B | |
+22.98% | 12B | |
+24.98% | 11.92B |
- Stock Market
- Equities
- DGCRF Stock
- News 9342-8530 Québec Inc.
- Declaration of Voting Results by DiagnoCure